Details for 2018740615

Up to date per 04.04.2026

Actions

Title / Product Name

KOMBINATION AUS PALBOCICLIB UND 6-(2,4-DICHLOROPHENYL)-5-[4-[(3S)-1-(3-FLUOROPROPYL)PYRROLIDIN-3-YL]OXYPHENYL]-8,9-DIHYDRO-7H-BENZO[7]ANNULEN-2-CARBOXYLSÄURE UND SEINE VERWENDUNG ZUR BEHANDLUNG VON KREBS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2018740615

EP Publication Number

3658147

E-Number

1445430

Language

PCT Number

EP18069901

Publication Date

03.06.2020 A

10.11.2021 B1

Registration Date

10.11.2021

AT Publication Date

15.11.2021

Application Date

23.07.2018

Registration Number

Priorities

24.07.2017

201762536121 P

25.07.2017

17305998

IPC

A61K 31/519 20060101AFI20190201BHEP

Maximum Duration of Protection

23.07.2038

Owner

Sanofi46 Avenue de la Grande Armée75017 ParisFR

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT

Inventor

BOUABOULA, Monsif 75008 ParisFR

SHOMALI, Maysoun Bridgewater, New Jersey 08807US

SUN, Fangxian Bridgewater, New Jersey 08807US